Nexus Surgical and Medicare Limited

Nexus Surgical and Medicare Limited

BBSE:NEXUSSURGL
26.36
INR
-1.38
(-4.97%)
1.44EPS
14.58P/E
114.91MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.16
0.79
0.6
0.56
1.79
3.91
3.16
6.84
4.38
2.84
6.35
10.46
14.38
15.88
Basic EPS, GAAP
0.09
0.27
0.09
-0.35
-0.6
-0.2
-9.68
0.28
0.53
0.31
0.39
0.91
1.35
1.44
Free Cash Flow per Basic Share
- -
0.06
-0.06
-0.3
-0.13
0.04
0.44
0.36
-0.2
1
-0.76
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
10.21
10.35
10
9.4
9.2
-0.48
-0.2
0.33
0.65
1.03
1.94
3.29
- -
Tangible Book Value per Share
- -
10.21
10.35
10
9.4
9.2
-0.48
-0.2
0.33
0.65
1.03
1.94
3.29
- -
Basic Weighted Avg Shares
6
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
1
4
3
3
10
21
17
37
24
16
35
57
79
87
Operating Margin (%)
80.56
49.28
29.74
-60.35
-39.22
-8.54
6.55
4.33
15.3
13.96
8.05
13.54
12.5
11.51
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
1
- -
-2
-3
-1
-53
2
3
2
2
5
7
8
Effective Tax Rate (%)
33.47
31.03
31.74
- -
- -
- -
- -
9.62
25.23
25.39
26.62
25.53
25.46
25.44
Profit Margin (%)
53.6
33.98
14.88
-63.2
-33.33
-5.21
-305.79
4.11
12.12
10.99
6.14
8.69
9.36
9.07
Working Capital
- -
2
2
1
-3
-4
-3
-2
- -
3
5
10
18
- -
LT Debt
- -
- -
- -
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
56
57
55
51
50
-3
-1
2
4
6
11
18
- -
Return on Invested Capital (%)
- -
- -
0.86
- -
- -
- -
- -
- -
737.72
60.46
44.63
62.87
47.9
- -
Return on Capital (%)
- -
- -
0.94
- -
- -
- -
- -
-83.26
781.39
63.79
46.41
61.03
51.42
- -
Return on Common Equity (%)
- -
- -
0.87
-3.46
-6.14
-2.19
- -
- -
- -
63.79
46.41
61.03
51.42
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
96
88
115

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
36
- -
Cash, Cash Equivalents & STI
- -
5
- -
Accounts Receivable, Net
- -
13
- -
Inventories
- -
4
- -
Total Current Liabilities
- -
19
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.32%
8.47%
69.21%
Free Cash Flow
30.75%
-192.44%
66.09%
Net Income, GAAP
431.37%
50.68%
48%
Sales/Revenue/Turnover
58.41%
30.94%
37.53%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
18
10
15
15
57
2026
17
12
29
20
79
2027
25
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.16
0.38
0.21
0.16
0.91
2026
0.28
0.32
0.31
0.44
1.35
2027
0.37
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Anish More
Full Time Employees
- -
Sector
Distribution services
Industry
Medical distributors
Address
Saarthak, Building No. 1 Palghar MH India 401 208
IPO Date
Jan 8, 2015
Business
Nexus Surgical and Medicare Ltd. (BSE: NEXUSSURGL.BO) imports and markets surgical and pharmaceutical products at economical prices primarily in India. The company trades a range of medical supplies including disposable syringes in various sizes from 5 ml to 50 ml both with needle (luer slip and luer lock variants) and without needle; sterilization pouches in gussetted and flat formats such as 15 cm x 40 cm, 25 cm x 50 cm, and 10 cm x 30 cm for storage of sterilized equipment and materials. It operates as a wholesale dealer targeting healthcare providers and holds necessary import licenses while planning expansion into additional surgical consumables like dressing materials and gloves. Founded in 1992 and headquartered in Indore, India with a registered office in Palghar, Maharashtra, the company listed its equity shares on the Bombay Stock Exchange in January 2015. Recent financial performance shows net profit rising 138.10% to Rs 0.50 crore for the fiscal year ended March 2025 with sales up 64.84% to Rs 5.72 crore; in the September 2025 quarter net profit declined 19.05% to Rs 0.17 crore amid 18.18% sales growth to Rs 1.17 crore.